News & Stories

Researchers report advance in immunotherapy against ALS

2023 08 News UCLA Health

New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.

ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects the nerve cells in the brain and spinal cord. It leads to the gradual loss of muscle control, eventually resulting in paralysis and difficulty with speech, swallowing, and breathing. The exact cause of ALS is not fully understood, and currently, there is no cure for the disease.

Share This Article: